devgenは、ソフトウェア開発ライフサイクルを加速させるために設計されたAI搭載のコーディングアシスタントです。開発者のIDE内で直接、インテリジェントなコード生成、補完、リファクタリング、自動テストを提供し、より良いコードをより速く書くのを支援します。
imbueは、推論とコーディングが可能なAIエージェントを構築するAI研究・製品会社です。主力製品であるSculptorは、安全なサンドボックス環境で問題を自動検出し、テストを生成し、バグを修正することで、開発者が高品質で信頼性の高いソフトウェアを作成するのを支援するコーディングエージェント環境です。
製品概要
Devgen 製品概要
devgenは、ソフトウェア開発ライフサイクルを加速させるために設計されたAI搭載のコーディングアシスタントです。開発者のIDE内で直接、インテリジェントなコード生成、補完、リファクタリング、自動テストを提供し、より良いコードをより速く書くのを支援します。
Imbue 製品概要
imbueは、推論とコーディングが可能なAIエージェントを構築するAI研究・製品会社です。主力製品であるSculptorは、安全なサンドボックス環境で問題を自動検出し、テストを生成し、バグを修正することで、開発者が高品質で信頼性の高いソフトウェアを作成するのを支援するコーディングエージェント環境です。
Detailed feature comparison
Devgen vs Imbue monthly traffic
Compare Devgen and Imbue by monthly reach, traffic trend, visit depth, top regions, and acquisition sources.
How to interpret the traffic data
In the Devgen vs Imbue monthly traffic comparison, Devgen currently shows 56K visits and Imbue shows 49.5K; Devgen has about 1.1 times the visible traffic of Imbue, an absolute difference of about 6.5K visits. This reflects visible reach, not feature quality or paid users.
Only Imbue has complete third-party traffic details; Devgen uses visits recorded inside ToolMage. These scopes cannot estimate market share directly, and on-site views should not be treated as the product’s total website traffic.
Devgen monthly traffic:
Latest traffic
Imbue monthly traffic:
Latest traffic
Monthly traffic trend
- 2025/9: 39.8K 月間訪問数
- 2026/1: 29K 月間訪問数
- 2026/2: 30.1K 月間訪問数
- 2026/3: 48.8K 月間訪問数
- 2026/4: 69.8K 月間訪問数
- 2026/5: 49.5K 月間訪問数
主要地域
Top 5 countries/regions
| Country/region | Percentage | Traffic |
|---|---|---|
| 🇺🇸United States | 67.08% | 33.2K |
| 🇨🇦Canada | 11.75% | 5.8K |
| 🇬🇧United Kingdom | 8.37% | 4.1K |
| 🇮🇳India | 6.42% | 3.2K |
| 🇰🇷Korea, Republic of | 6.38% | 3.2K |
流入元
| Source type | Percentage | Traffic |
|---|---|---|
| ダイレクト | 66.94% | 33.1K |
| 参照元 | 25.83% | 12.8K |
| Eメール | 7.23% | 3.6K |
検索キーワード
Usage comparison
Compare the core capabilities of Devgen and Imbue
Devgen Core features
Imbue Core features
Use cases
Devgen Use cases
Imbue Use cases
Best suited roles
Devgen Best suited roles
Imbue Best suited roles
Devgen vs Imbue:In-depth comparison and selection guidance
First decide whether the products solve the same kind of need
This in-depth Devgen vs Imbue comparison uses only the product records, taxonomy, audience, traffic, and community signals available on this page. Devgen is primarily listed under “コードアシスタント”, while Imbue is primarily listed under “機械学習”, so the first decision is whether your actual task matches their recorded scope.
The structured fields currently show these decision-relevant differences: Primary category (Devgen: コードアシスタント; Imbue: 機械学習); Pricing (Devgen: Freemium; Imbue: Not disclosed); Monthly visits (Devgen: 56K; Imbue: 49.5K); Favorites (Devgen: 141; Imbue: 127); Website (Devgen: www.godaddy.com; Imbue: imbue.com). These facts are more useful for selection than brand visibility alone.
What market visibility and monthly traffic mean
In the Devgen vs Imbue monthly traffic comparison, Devgen currently shows 56K visits and Imbue shows 49.5K; Devgen has about 1.1 times the visible traffic of Imbue, an absolute difference of about 6.5K visits. This reflects visible reach, not feature quality or paid users.
Only Imbue has complete third-party traffic details; Devgen uses visits recorded inside ToolMage. These scopes cannot estimate market share directly, and on-site views should not be treated as the product’s total website traffic.
The current traffic scope is not sufficient for a reliable product ranking. Treat monthly visits as a market-interest signal, then decide using taxonomy, use cases, pricing, and a like-for-like trial rather than reading exposure as product capability.
Product positioning, use cases, and roles
Devgen and Imbue currently overlap in shared categories: コードアシスタント、自動化; shared tags: コード生成、開発者ツール、リファクタリング、ソフトウェア開発; shared roles: DevOpsエンジニア、ソフトウェア開発者. This can place both on the same shortlist, but it does not prove equal implementation, depth, or cost.
Devgen's unique categories/tags are テスト、AIアシスタント、AIペアプログラマー、コード補完、IDE拡張機能、プログラミング、単体テスト; Imbue's are 機械学習、AIコーディングエージェント、自動テスト、バグ検出、コード品質、大規模言語モデル、推論、サンドボックス. These unique fields are the strongest differentiators: validate the product whose recorded scope matches the task instead of following traffic alone.
What ratings, comments, and favorites can tell you
Devgen has no verified rating, 0 comments, 141 favorites, and 138 likes;Imbue has no verified rating, 0 comments, 127 favorites, and 129 likes。
Neither product has enough rating or comment samples for a credible reputation ranking.
Selection guidance by actual need
When to evaluate Devgen first
Put Devgen on the priority trial list when the task aligns with “コードアシスタント” and especially テスト、AIアシスタント、AIペアプログラマー、コード補完、IDE拡張機能、プログラミング, or the users include データサイエンティスト、プロダクトマネージャー、ソフトウェアエンジニア、学生. This follows recorded positioning and does not imply unlisted capabilities are absent.
Devgen also currently records: pricing is freemium, product type is website, 56K on-site monthly views, no verified user rating. Verify any hard requirement around price, platform, or reach before trial, and do not let sparse review data substitute for testing.
When to evaluate Imbue first
Put Imbue on the priority trial list when the task aligns with “機械学習” and especially 機械学習、AIコーディングエージェント、自動テスト、バグ検出、コード品質、大規模言語モデル, or the users include AIエンジニア、フルスタック開発者、プロダクトエンジニア、品質保証エンジニア. This follows recorded positioning and does not imply unlisted capabilities are absent.
Imbue also currently records: pricing is not verified, product type is website, 49.5K verified monthly visits, no verified user rating. Verify any hard requirement around price, platform, or reach before trial, and do not let sparse review data substitute for testing.
How to validate the recommendation before deciding
The available data describes positioning, public visibility, and community signals, but it cannot prove output quality, speed, integration effort, privacy, or long-term cost in your workflow. Before deciding, run the same representative tasks in Devgen and Imbue, then record completion time, accuracy, manual corrections, and the real paid threshold. A like-for-like trial turns this comparison into a defensible adoption decision.




